Goals of Clinical Trials Include:

  • Testing ways to diagnose a disease early, sometimes before there are symptoms.
  • Finding ways to possibly prevent a health problem, including people who are healthy but at increased risk of developing a disease.
  • Potentially improving quality of life for people living with a life-threatening disease or chronic health problem.
  • Learning from caregivers and support groups to better understand their role, experiences, and impact on patient outcomes.

Living with a disease or condition impacting your health, or the health of a loved one, can be stressful or even life-altering. But new investigational interventions are constantly in development for hundreds of diseases—many of which are being tested today in patients and healthy volunteers through clinical trials. Otsuka's dedication to patients drives innovation, and clinical trials are how we discover better ways to treat diseases.

Types of Clinical Trials

There are two types of clinical trials researchers use:

1Interventional
2Observational

Interventional Clinical Trials

Interventional trials are the most common type of clinical study. They test new treatments—like medicines, diets, or medical devices—to see if they are safe and if they work.

In these studies, some people get the new treatment, while others might get the usual treatment or a placebo (which looks like the treatment but doesn’t have any active ingredients). This helps researchers compare results and learn what works best.

Clinical Trial Phases

Clinical trials of investigational treatments and therapeutics are conducted in phases, with each phase building on the information learned in the previous phase. Each phase of a trial has a different purpose and helps researchers answer different questions. At each phase, potential participants are provided with information gained from previous research to help them make an informed decision about joining a study.

For more information about the phases of clinical research, please view this infographic.

Click on the different Phases listed below to see a description of each

Step 1
Phase 1

The main focus of Phase 1 studies is to examine an intervention’s safety and see how it interacts with the body, typically with healthy volunteers who do not have the condition being studied. If the test is for a drug, it can include researching the effects of different dosages. This phase takes several months to complete, but each participant is not in the trial for the whole duration of the phase.

Step 2
Phase 1/2

These studies combine the first two phases of testing to look at both safety and early signs of effectiveness at the same time. Researchers start by giving small doses of the treatment to a few participants to find the highest amount that can be given safely. Once the safest dose is identified, more participants are added to see whether the treatment begins to show positive effects on the condition being studied. The study continues without a pause between phases, and researchers carefully monitor safety throughout.

Step 3
Phase 2

Phase 2 studies focus on intervention effectiveness of providing treatment or therapy to those with the condition being researched while also collecting data about safety and side effects. This phase takes an average of 3 years to complete, but each participant is not in the trial for the whole duration of the phase.

Step 4
Phase 2/3

In these trials, researchers test different doses of a new treatment to find the safest and most effective one. They start by removing doses that don't work well or cause too many side effects, then adjust the study to focus on the best dose. This dose is then tested on more participants to confirm its safety and effectiveness without any breaks between the phases. This process helps ensure that the treatment is both safe and effective before it is widely used.

Step 5
Phase 3

Phase 3 trials compare the safety and efficacy of the investigative treatment to the current standard of treatment. These trials typically take 1 to 4 years and includes hundreds to thousands of participants with the disease being researched.

Step 6
Phase 4

Testing continues after an intervention is approved. Phase 4 studies determine the effectiveness and safety of interventions when used by the public in daily life, and collect additional data on benefits, risks, and quality of life.

Safety Guardrails in Clinical Trials

Participants are valued and treated with quality care and closely monitored throughout the trial to ensure a patient's health and safety. Participation is always voluntary, and participants can choose to stop participation in the trial at any time.

Anyone thinking about joining a clinical trial must weigh the risks and benefits. It's important to discuss participation with your doctor so you are fully aware of all considerations.

View this infographic to see suggested questions to help you start the conversation.

Step 1
What are the potential benefits of participating in a clinical trial?

Participating in a clinical trial provides the opportunity to play an important role in medical research. This research could lead to better healthcare outcomes for yourself or others in the future.

Some benefits of participating in a clinical trial can include:

  • Playing a more active role in your own health care.
  • Receiving additional study-related check-ups by researchers.
  • Possible early access to an investigational treatment before it is available to the general public.
  • Having the chance to help others by identifying treatment options for others who are affected by disease or condition.

Step 2
What are the potential risks of participating in a clinical trial?

Clinical trials are designed with the highest ethical and safety standards and require the review and approval of numerous review boards, such as an Institutional Review Board (IRB) that ensures the risks are minimal compared to the potential benefit. Clinical Trials conducted in the United States must also adhere to all FDA regulations and Good Clinical Practice standards to ensure clinical trials are safe and ethical.

With this said, participating in a clinical trial, may still carry risks, including:

  • The inability to choose the intervention you receive, including the dosage level or if you get a placebo, which contains no active drug.
  • The investigation intervention might not be better than available interventions.
  • There is a chance of experiencing unwanted side effects.
  • Participation in a clinical trial may require you to manage complex medication doses, to have additional or longer medical appointments, more procedures, or hospital stays.

Summary of Results for Trial Participants

What is a Plain Language Summary?

Everyone deserves to understand Clinical Trial Results. Plain Language Summaries (PLS) transform complex data into clear simple language making vital information accessible to all. It includes information about the purpose, treatment, side effects, results and other facts about the trial. These summaries are translated into the local language of the country in which the trial was conducted.

When will the Plain Language Summary be available?

After a clinical trial is completed, it will take about a year or more before plain language summaries from that trial are available for download. As of 2026 we are generating a PLS for all Phase 1-4 interventional trials, regardless of region.

Where can I find Plain Language Summaries? Otsuka Clinical Trial Transparency

© 2026 Otsuka America Pharmaceutical, Inc.

All rights reserved.

June 2026 01US26EUC0129

We defy limitation,

so that others can too.

Follow Us
OAPI and OPDC Locations

508 Carnegie Center Dr,

Princeton, NJ 08540, United States

Phone +1 609-524-6788

2440 Research Blvd,

Rockville, MD 20850, United States

Phone +1 301-424-9055

3956 Point Eden Way

Hayward, CA 94545, United States

Phone +1 800-562-3974